New eye treatment shows promise for common vision loss condition
NCT ID NCT07420361
First seen Feb 22, 2026 · Last updated May 05, 2026 · Updated 9 times
Summary
This study tested a treatment called transcleral lutein iontophoresis in 30 people with intermediate age-related macular degeneration and a specific type of eye deposit. The treatment uses a mild electrical current to deliver lutein, a nutrient, into the eye. Researchers looked at safety and whether it improved vision and eye structure over 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERMEDIATE AGE-RELATED MACULAR DEGENERATION WITH RETICULAR PSEUDODRUSEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federico II
Naples, Italy
Conditions
Explore the condition pages connected to this study.